Spatial transcriptomic gene expression profiles in breast cancer progression

August 24, 2026

Dr. Darren Segale of Illumina presents a spatial transcriptomics study of breast cancer progression from normal tissue through ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC), using Illumina StrataMap Spatial solution to profile 2.5M+ cells at single-cell resolution across tumor grades. The talk highlights how whole transcriptome spatial profiling reveals distinct fibroblast and macrophage cell populations and identifies potentially novel biomarkers associated with IDC cancer progression. Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars https://www.youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos https://www.youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: https://www.linkedin.com/company/illumina X: https://x.com/illumina Instagram: https://www.instagram.com/illuminainc/ Facebook: https://www.facebook.com/illuminainc TikTok: https://www.tiktok.com/@illuminainc #spatial #spatialomics #stratamapspatial

Share this article on